Dren Bio website screenshot

Dren Bio

Dren Bio is a clinical-stage biopharmaceutical company based in Foster City, California, focused on the discovery and development of novel antibody therapeutics that selectively deplete pathogenic cells and other disease-causing agents. Its proprietary Targeted Myeloid Engager and Phagocytosis Platform is a multispecific, antibody-based technology designed to induce potent depletion of disease-causing agents by engaging a novel phagocytic receptor selectively expressed on myeloid cells. The pipeline spans two first-in-class clinical-stage programs (including DR-01 and DR-0202) plus multiple preclinical and discovery-stage programs across oncology, autoimmune disease, immunology, and neurology. Dren Bio has established strategic collaborations with Pfizer and Sanofi, the latter of which acquired its DR-0201 (SAR448501) bispecific myeloid cell engager program. The company was surfaced as a portfolio company of 8vc and added to the API Evangelist network. It publishes no public API or developer surface; this profile captures its identity and public web properties.

Dren Bio is profiled on the APIs.io network. Tagged areas include Company, Biopharmaceutical, Biotechnology, Antibody Therapeutics, and Oncology.

Dren Bio’s developer surface includes support, engineering blog, and 4 more developer resources.

10.6/100 minimal ▬ flat Agent 0/100 human only saas Full breakdown ↓
scored 2026-09-08 · rubric v0.20.0
0 APIs
CompanyBiopharmaceuticalBiotechnologyAntibody TherapeuticsOncologyAutoimmuneImmunologyNeurologyDrug Development

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-09-08 · rubric v0.20.0
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero: never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and several others — scorable at all.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. Every facet and dimension name above is a link: it opens that measurement's own page — what it means, the exact checks that feed it, how the whole catalog distributes on it, and the providers at the top of it. This rating is computed from github.com/api-evangelist/dren-bio: open an issue to ask a question, or submit a pull request to add artifacts. Submit an artifact on GitHub — free → Manage your own listing — the Influence plan, $499/mo →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Dren Bio Domain Security

TLSv1.2 · DMARC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

Operate 1

Status, limits, changes, and where to get help

Commercial 2

Pricing, plans, and the legal terms of use

Company 2

The organization behind the API

Source (apis.yml)

apis.yml Raw ↑
aid: dren-bio
deliveryModel:
  model: saas
  open_source: false
  commercial: true
  callable_host: false
  label: Hosted service · you call their endpoint
  confidence: medium
  source:
  - pricing
  generated: '2026-08-28'
  method: derived
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/dren-bio.png
name: Dren Bio
description: Dren Bio is a clinical-stage biopharmaceutical company based in Foster City, California, focused on the discovery
  and development of novel antibody therapeutics that selectively deplete pathogenic cells and other disease-causing agents.
  Its proprietary Targeted Myeloid Engager and Phagocytosis Platform is a multispecific, antibody-based technology designed
  to induce potent depletion of disease-causing agents by engaging a novel phagocytic receptor selectively expressed on myeloid
  cells. The pipeline spans two first-in-class clinical-stage programs (including DR-01 and DR-0202) plus multiple preclinical
  and discovery-stage programs across oncology, autoimmune disease, immunology, and neurology. Dren Bio has established strategic
  collaborations with Pfizer and Sanofi, the latter of which acquired its DR-0201 (SAR448501) bispecific myeloid cell engager
  program. The company was surfaced as a portfolio company of 8vc and added to the API Evangelist network. It publishes no
  public API or developer surface; this profile captures its identity and public web properties.
url: https://raw.githubusercontent.com/api-evangelist/dren-bio/refs/heads/main/apis.yml
x-api-posture: no-product-api
x-api-posture-basis: observed
x-api-posture-note: It publishes no public API or developer surface; this profile captures its identity and public web properties.
x-type: company
x-source: vc-portfolio
x-backed-by:
- 8vc
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-07-18'
tags:
- Company
- Biopharmaceutical
- Biotechnology
- Antibody Therapeutics
- Oncology
- Autoimmune
- Immunology
- Neurology
- Drug Development
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://drenbio.com
- type: Support
  url: https://www.drenbio.com/contact.html
- type: Blog
  url: https://www.drenbio.com/news.html
- type: PrivacyPolicy
  url: https://www.drenbio.com/privacy.html
- type: TermsOfService
  url: https://www.drenbio.com/termsofuse.html
- type: DomainSecurity
  url: security/dren-bio-domain-security.yml
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence

Work with this as data

Every provider here is available over the APIs.io API and to AI agents over MCP.

MCP server

One button, every client — Claude, Cursor, VS Code and the rest.

https://apis.io/mcp

Tools for providers

9 MCP tools reach this
  • find_providersBrowse and filter every provider in the catalog.
  • get_provider_artifactsEvery artifact this provider publishes, grouped by type.
  • get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
  • get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
  • get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
  • get_provider_ratingPRO — composite, band, trend and facet scores.
  • apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
  • resolveTurn a domain, URL or GitHub org into the provider it belongs to.
  • find_cohortsEvery scored population of providers in the catalog.
All 92 tools →

Call it yourself

curl for this page
This provider
curl "https://apis.io/api/v1/providers/dren-bio"
All providers
curl "https://apis.io/api/v1/providers?limit=25"
Every operation they expose
curl "https://apis.io/api/v1/providers/dren-bio/operations?limit=25"
How their score was established
curl "https://apis.io/api/v1/providers/dren-bio/evidence"

Discovery needs no key. Ratings and market analysis are Pro.

Get an API key

Free tier, no form to fill in. Signing in shares your email address with us — we store it to create your key and to recognise you if you sign in with another provider. See our Privacy Policy and Terms.

A second provider on the same verified email joins the account you already have.